Learn more

NANJING HUAWE MEDICINE TECH GROUP CO LTD

Overview
  • Total Patents
    17
  • GoodIP Patent Rank
    99,462
  • Filing trend
    ⇧ 300.0%
About

NANJING HUAWE MEDICINE TECH GROUP CO LTD has a total of 17 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2017. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are EWING WILLIAM R, OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES and TANIGUCHI TAKAHIKO.

Patent filings in countries

World map showing NANJING HUAWE MEDICINE TECH GROUP CO LTDs patent filings in countries

Patent filings per year

Chart showing NANJING HUAWE MEDICINE TECH GROUP CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhang Xiaoqing 16
#2 Bao Jinyuan 15
#3 Song Zhichun 15
#4 He Dongwei 5
#5 Huang Hui 4
#6 Zou Zhengcai 3
#7 Zhang Chongguang 3
#8 Yang Kai 2
#9 Xu Xiaohe 1
#10 Xu Leiming 1

Latest patents

Publication Filing date Title
CN112250711A Industrial synthesis method of propane fumarate tenofovir
WO2021051827A1 Apoptosis protein inhibitor, preparation method therefor, and use thereof
CN111138416A Preparation method of L-sunitinib malate E-type isomer
CN110330479A A kind of antitumoral compounds and application thereof as AXL inhibitor
CN110028508A A kind of antitumor diazo bicyclic class apoptosis protein inhibitor
CN111087462A Solid-phase synthesis method of abamectin
CN111057139A Novel process for preparing teriparatide
CN110964097A Synthesis of exenatide by solid-phase fragment method
CN110894227A Solid-phase synthesis method of liraglutide
CN108484640A A kind of antitumor apoptosis protein inhibitor
CN108586378A Indoleamine 2,3- is bis- to add oxidase inhibitor and its preparation method and application
WO2018184392A1 Indoleamine 2,3-dioxygenase inhibitor containing hydrazino group
WO2018227886A1 New type indoleamine 2,3-dioxygenase inhibitor